General
Preferred name
ISRIB (trans-isomer)
Synonyms
ISRIB trans-isomer ()
trans-ISRIB ()
ISRIB ()
P&D ID
PD012842
CAS
1597403-47-8
Tags
available
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
ISRIB (trans-isomer) is a potent inhibitor of PERK with an IC50 of 5 nM. ISRIB potently reverses the effects of eIF2¦Á phosphorylation (IC50=5 nM).
PRICE
93
DESCRIPTION
ISRIB (trans-isomer) is a potent inhibitor of PERK (IC50=5 nM) that restores protein translation and prevents SG formation in the presence of P-eIF2??.
DESCRIPTION
Allosteric AMPK activator
(Tocris Bioactive Compound Library)
DESCRIPTION
ISRIB (trans-isomer) is a potent inhibitor of PERK (IC50=5 nM) that restores protein translation and prevents SG formation in the presence of P-eIF2α.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
10
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Cayman Chemical Bioactives
Drug Repurposing Hub
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
Other bioactive compounds
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
12
Molecular Weight
450.11
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
8
Ring Count
3
Aromatic Ring Count
2
cLogP
3.99
TPSA
76.66
Fraction CSP3
0.36
Chiral centers
0.0
Largest ring
6.0
QED
0.64
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Apoptosis
Autophagy
Cell Cycle/DNA Damage
Primary Target
PERK
MOA
ERK inhibitor
Inhibits UPR, reactives translation
EIF2B4 modulator
eukaryotic translation initiation factor inhibitor, PERK inhibitor
Member status
member
Target
EIF2A, EIF2AK3
ISR inhibitor
Source data

